Lund, Sweden

Björn Walse

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Uppsala, SE (2014 - 2015)
  • Lund, SE (2011 - 2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Björn Walse: Innovator in Peptide Research

Introduction

Björn Walse is a prominent inventor based in Lund, Sweden. He has made significant contributions to the field of peptide research, particularly in the treatment of metabolic diseases and inflammation. With a total of 8 patents, Walse's work has the potential to impact medical treatments significantly.

Latest Patents

Walse's latest patents include innovative peptides aimed at treating diabetes. The disclosure concerns agents and their use in the treatment of endocrine, nutritional, and metabolic diseases in mammals. Additionally, he has developed heparin cofactor II fragments that exhibit anti-inflammatory and anti-coagulant activity. This invention provides polypeptides that modulate blood coagulation, offering new avenues for treating or preventing inflammation and excessive blood coagulation.

Career Highlights

Throughout his career, Björn Walse has worked with notable companies such as Alligator Bioscience AB and Pergamum AB. His experience in these organizations has allowed him to advance his research and contribute to the development of groundbreaking medical treatments.

Collaborations

Walse has collaborated with esteemed colleagues, including Eva Maria Dahlén and Patrick Thomas Höjman. These partnerships have fostered a collaborative environment that enhances innovation and research in peptide technology.

Conclusion

Björn Walse's contributions to peptide research and his innovative patents position him as a key figure in the medical field. His work continues to pave the way for advancements in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…